Related Experiment Videos
A novel stop codon mutation in the PMP22 gene associated with a variable phenotype.
K T Abe1, A M M Lino, M T A Hirata
1Departamento de Biologia, Instituto de Biociências, Universidade de São Paulo, Rua do Matao 277 CEP, São Paulo 05508-900, Brazil.
Neuromuscular Disorders : NMD
|April 22, 2004
Summary
A novel mutation in the peripheral myelin protein 22 (PMP22) gene causes Charcot-Marie-Tooth type 1 disease with variable symptoms. This suggests other factors influence disease severity beyond the PMP22 mutation itself.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Inherited peripheral neuropathies are common, with peripheral myelin protein 22 (PMP22) gene mutations being the most frequent cause.
- PMP22 gene alterations, including duplications, deletions, and point mutations, lead to diverse clinical presentations.
Purpose of the Study:
- To investigate a family with a novel mutation in the PMP22 gene.
- To understand the relationship between this specific PMP22 mutation and the resulting phenotype.
Main Methods:
- Genetic sequencing to identify mutations in the PMP22 gene.
- Clinical evaluation of family members carrying the mutation.
Main Results:
- Identification of a novel PMP22 gene mutation (c. 327C>A) causing a premature stop codon (Cys109stop).
- Family members with this mutation exhibited a variable Charcot-Marie-Tooth type 1 phenotype, from asymptomatic to severe.
- The fourth transmembrane domain of PMP22 appears functionally significant.
Conclusions:
- The novel PMP22 mutation leads to a variable Charcot-Marie-Tooth type 1 phenotype.
- Clinical variability highlights that mutations are not always deterministic; genetic or epigenetic factors modulate disease severity.